Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response

Ulcerative colitis (UC) is a complex intestinal inflammation with an increasing risk of colitis-associated colorectal cancer (CAC). However, the pathogenesis is still unclear between active UC and inactive UC. Recently, it has been reported that pyroptosis-related genes (PRGs) are closely associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Yumei Ning, Kun Lin, Jun Fang, Xiaojia Chen, Xinyi Hu, Lan Liu, Qiu Zhao, Haizhou Wang, Fan Wang
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2023/7040113
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559526569574400
author Yumei Ning
Kun Lin
Jun Fang
Xiaojia Chen
Xinyi Hu
Lan Liu
Qiu Zhao
Haizhou Wang
Fan Wang
author_facet Yumei Ning
Kun Lin
Jun Fang
Xiaojia Chen
Xinyi Hu
Lan Liu
Qiu Zhao
Haizhou Wang
Fan Wang
author_sort Yumei Ning
collection DOAJ
description Ulcerative colitis (UC) is a complex intestinal inflammation with an increasing risk of colitis-associated colorectal cancer (CAC). However, the pathogenesis is still unclear between active UC and inactive UC. Recently, it has been reported that pyroptosis-related genes (PRGs) are closely associated with inflammatory disease activity. Nevertheless, the specific roles of PRGs in the progression and treatment of UC and CAC remain unclear. In this study, we identified 30 differentially expressed PRGs based on the immune landscape of active and inactive UC samples. Meanwhile, weighted gene coexpression network analysis was applied to explore important genes associated with active UC. By intersecting with the differentially expressed PRGs, CASP5, GBP1, GZMB, IL1B, and IRF1 were selected as key PRGs to construct a pyroptosis-related signature (PR-signature). Then, logistic regression analysis was performed to validate the PR-signature and establish a pyroptosis-related score (PR-Score). We demonstrated that PR-Score had a powerful ability to distinguish active UC from inactive UC in multiple datasets. Besides, PR-Score was positively correlated with immune cell infiltration and inflammatory microenvironment in UC. Lower PR-Score was associated with a better response to anti-TNF therapy for patients with UC. Additionally, high-PR-Score was found to suppress CAC and improve the survival outcomes of patients with colorectal cancer. Finally, the levels of the PR-signature genes were validated both in vitro and in vivo. These findings can improve our understanding of PRGs in UC and provide new markers for predicting the occurrence of active UC or CAC and the treatment of UC.
format Article
id doaj-art-ed51b8a6b97c45c184d5cdff471d5e3d
institution Kabale University
issn 2314-7156
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-ed51b8a6b97c45c184d5cdff471d5e3d2025-02-03T01:29:53ZengWileyJournal of Immunology Research2314-71562023-01-01202310.1155/2023/7040113Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic ResponseYumei Ning0Kun Lin1Jun Fang2Xiaojia Chen3Xinyi Hu4Lan Liu5Qiu Zhao6Haizhou Wang7Fan Wang8Department of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyUlcerative colitis (UC) is a complex intestinal inflammation with an increasing risk of colitis-associated colorectal cancer (CAC). However, the pathogenesis is still unclear between active UC and inactive UC. Recently, it has been reported that pyroptosis-related genes (PRGs) are closely associated with inflammatory disease activity. Nevertheless, the specific roles of PRGs in the progression and treatment of UC and CAC remain unclear. In this study, we identified 30 differentially expressed PRGs based on the immune landscape of active and inactive UC samples. Meanwhile, weighted gene coexpression network analysis was applied to explore important genes associated with active UC. By intersecting with the differentially expressed PRGs, CASP5, GBP1, GZMB, IL1B, and IRF1 were selected as key PRGs to construct a pyroptosis-related signature (PR-signature). Then, logistic regression analysis was performed to validate the PR-signature and establish a pyroptosis-related score (PR-Score). We demonstrated that PR-Score had a powerful ability to distinguish active UC from inactive UC in multiple datasets. Besides, PR-Score was positively correlated with immune cell infiltration and inflammatory microenvironment in UC. Lower PR-Score was associated with a better response to anti-TNF therapy for patients with UC. Additionally, high-PR-Score was found to suppress CAC and improve the survival outcomes of patients with colorectal cancer. Finally, the levels of the PR-signature genes were validated both in vitro and in vivo. These findings can improve our understanding of PRGs in UC and provide new markers for predicting the occurrence of active UC or CAC and the treatment of UC.http://dx.doi.org/10.1155/2023/7040113
spellingShingle Yumei Ning
Kun Lin
Jun Fang
Xiaojia Chen
Xinyi Hu
Lan Liu
Qiu Zhao
Haizhou Wang
Fan Wang
Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
Journal of Immunology Research
title Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
title_full Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
title_fullStr Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
title_full_unstemmed Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
title_short Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
title_sort pyroptosis related signature predicts the progression of ulcerative colitis and colitis associated colorectal cancer as well as the anti tnf therapeutic response
url http://dx.doi.org/10.1155/2023/7040113
work_keys_str_mv AT yumeining pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT kunlin pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT junfang pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT xiaojiachen pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT xinyihu pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT lanliu pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT qiuzhao pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT haizhouwang pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse
AT fanwang pyroptosisrelatedsignaturepredictstheprogressionofulcerativecolitisandcolitisassociatedcolorectalcanceraswellastheantitnftherapeuticresponse